Komisar J L, Small-Harris S, Tseng J
Department of Experimental Pathology, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.
Infect Immun. 1994 Nov;62(11):4775-80. doi: 10.1128/iai.62.11.4775-4780.1994.
Staphylococcal enterotoxins are major causes of food poisoning and toxic shock syndrome. Their ability to bind to major histocompatibility complex (MHC) class II molecules has been suggested to be the first step in the mechanism whereby they cause illness. By flow cytometric analysis, the sites of interaction of staphylococcal enterotoxin B (SEB) with HLA-DR molecules were probed in the present study by inhibiting the binding of biotinylated SEB to a human T-cell line (HUT-78) with synthetic peptides of SEB. Five peptides of SEB gave significant inhibition of binding: a peptide containing amino acids 9 to 20 [SEB(9-20)], SEB(30-38), SEB(61-70), SEB(90-114), and SEB(169-181). One peptide, SEB(39-51), enhanced binding. Among the inhibitory peptides, SEB(90-114), a peptide spanning the entire disulfide loop, showed the most efficient inhibition of binding. Peptides SEB(9-20) and SEB(39-51) include amino acid residues that have been identified by previous mutation studies (J.W. Kappler, A. Herman, J. Clements, and P. Marrack, J. Exp. Med. 175:387-396, 1992) as being important in binding to MHC class II. Amino acids lining the alpha 5 groove of SEB have also been postulated to be involved in binding to MHC class II molecules. However, only two of the residues that line the alpha 5 groove of SEB, His-12 and Tyr-17, are on peptide SEB(9-20) that inhibits binding. These results confirm previous studies that implicated the amino-terminal portion of the molecule in binding to MHC class II molecules and further indicate an important role for residues in other regions, particularly the disulfide loop.
葡萄球菌肠毒素是食物中毒和中毒性休克综合征的主要病因。它们与主要组织相容性复合体(MHC)II类分子结合的能力被认为是其致病机制的第一步。在本研究中,通过用葡萄球菌肠毒素B(SEB)的合成肽抑制生物素化SEB与人T细胞系(HUT-78)的结合,利用流式细胞术分析探究了SEB与HLA-DR分子的相互作用位点。SEB的五种肽对结合有显著抑制作用:一种包含氨基酸9至20的肽[SEB(9-20)]、SEB(30-38)、SEB(61-70)、SEB(90-114)和SEB(169-181)。一种肽SEB(39-51)增强了结合。在抑制性肽中,跨越整个二硫键环的肽SEB(90-114)对结合的抑制作用最为有效。肽SEB(9-20)和SEB(39-51)包含先前突变研究(J.W.卡普勒、A.赫尔曼、J.克莱门茨和P.马拉克,《实验医学杂志》175:387-396,1992)确定的在与MHC II类结合中起重要作用的氨基酸残基。SEB的α5凹槽内的氨基酸也被假定参与与MHC II类分子的结合。然而,SEB的α5凹槽内的残基中,只有His-12和Tyr-17这两个残基在抑制结合的肽SEB(9-20)上。这些结果证实了先前的研究,即该分子的氨基末端部分参与与MHC II类分子的结合,并进一步表明其他区域的残基,特别是二硫键环,具有重要作用。